Rayence Co

Rayence Co Retained Earnings

The Retained Earnings of Rayence Co (228850.KQ) as of Nov 7, 2026 is 138.92 B KRW. In the previous year, Retained Earnings was 145.62 B KRW — a change of -4.61% (lower).

Retained Earnings

138.92 BKRW

YoY

-4.61%

Last updated:

Retained Earnings of Rayence Co is 2025 138.92 B KRW. Retained Earnings of Rayence Co was 2024 145.62 B KRW. It decreases by -4.61% lower compared to the previous year.

The Rayence Co Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
81.57 B KRW
Jan 1, 2019
94.14 B KRW
Jan 1, 2020
89.41 B KRW
Jan 1, 2021
102.25 B KRW
Jan 1, 2022
123.43 B KRW
Jan 1, 2023
139.62 B KRW
Jan 1, 2024
145.62 B KRW
Jan 1, 2025
138.92 B KRW
The Rayence Co Retained Earnings history
YEARRetained EarningsYoY
138.92 BKRW-4.61%
145.62 BKRW+4.30%
139.62 BKRW+13.12%
123.43 BKRW+20.71%
102.25 BKRW+14.36%
89.41 BKRW-5.02%
94.14 BKRW+15.40%
81.57 BKRW+20.49%
67.70 BKRW+25.42%
53.98 BKRW+39.77%
38.62 BKRW+55.88%
24.78 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Retained Earnings of Rayence Co is 138.92 B KRW in 2025.

Retained Earnings of Rayence Co changed from 145.62 B KRW to 138.92 B KRW, representing a -4.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Rayence Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Rayence Co

All Key Metrics — Rayence Co